Novacyt S.A. announced that Edwin Snape has informed the Board that he wishes to retire after 14 years with the expanded Group, both as a Non-Executive Director of Novacyt and formerly NED of Lab21, which was acquired by the Group in 2014. Ed's retirement from the Board will take effect from 31 December 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.819 EUR | +2.89% | -1.33% | +14.87% |
04-19 | Novacyt: confident ahead of DHSC trial | CF |
04-19 | Novacyt expects court to dismiss application by UK DHSC | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.87% | 61.68M | |
-28.51% | 925M | |
-20.60% | 128M | |
-7.82% | 67.46M | |
+6.64% | 60.58M | |
+0.60% | 51.45M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt S.A. Announces Retirement of Non-Executive Director, Effective on 31 December 2022